Certified by Founder Lodge
Bioluminescence Ventures
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $50,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Bioluminescence Ventures is a biotechnology venture firm investing in the future of medicine. The firm focuses its investments on Drug Discovery Platforms, Applied Biology Platforms, and Comp
| Company | Date | Round | Raised |
|---|---|---|---|
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 Cerevance |
April, 26 ,2024 | Series B | $47,000,000 |
 GEMMA Biotherapeutics |
January, 06 ,2025 | Seed | $34,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
